nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—Crohn's disease	0.354	1	CbGaD
Trisalicylate-choline—PTGS2—Balsalazide—Crohn's disease	0.152	0.241	CbGbCtD
Trisalicylate-choline—PTGS1—Balsalazide—Crohn's disease	0.128	0.204	CbGbCtD
Trisalicylate-choline—PTGS2—Mesalazine—Crohn's disease	0.121	0.193	CbGbCtD
Trisalicylate-choline—PTGS1—Mesalazine—Crohn's disease	0.103	0.163	CbGbCtD
Trisalicylate-choline—PTGS2—Sulfasalazine—Crohn's disease	0.0678	0.108	CbGbCtD
Trisalicylate-choline—PTGS1—Sulfasalazine—Crohn's disease	0.0573	0.0911	CbGbCtD
Trisalicylate-choline—Magnesium salicylate—PTGS2—Crohn's disease	0.000756	0.365	CrCbGaD
Trisalicylate-choline—Magnesium salicylate—ALB—Crohn's disease	0.000674	0.325	CrCbGaD
Trisalicylate-choline—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX4—Crohn's disease	0.000646	0.137	CbGpPWpGaD
Trisalicylate-choline—Salsalate—PTGS2—Crohn's disease	0.000643	0.31	CrCbGaD
Trisalicylate-choline—Duodenal ulcer—Mesalazine—Crohn's disease	0.000588	0.0601	CcSEcCtD
Trisalicylate-choline—Upset stomach—Mesalazine—Crohn's disease	0.000433	0.0444	CcSEcCtD
Trisalicylate-choline—Burning sensation—Mesalazine—Crohn's disease	0.000409	0.0418	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Mesalazine—Crohn's disease	0.00031	0.0317	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—CREM—Crohn's disease	0.000295	0.0628	CbGpPWpGaD
Trisalicylate-choline—Skin exfoliation—Mesalazine—Crohn's disease	0.000271	0.0277	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Mesalazine—Crohn's disease	0.000257	0.0263	CcSEcCtD
Trisalicylate-choline—Deafness—Mesalazine—Crohn's disease	0.00023	0.0236	CcSEcCtD
Trisalicylate-choline—Lethargy—Mesalazine—Crohn's disease	0.00021	0.0215	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—Crohn's disease	0.000209	0.0444	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CREM—Crohn's disease	0.000191	0.0406	CbGpPWpGaD
Trisalicylate-choline—Abdominal pain upper—Mesalazine—Crohn's disease	0.000188	0.0193	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Azathioprine—Crohn's disease	0.000188	0.0192	CcSEcCtD
Trisalicylate-choline—Oedema—Mercaptopurine—Crohn's disease	0.000187	0.0191	CcSEcCtD
Trisalicylate-choline—Asthma—Mesalazine—Crohn's disease	0.000178	0.0182	CcSEcCtD
Trisalicylate-choline—Anorexia—Mercaptopurine—Crohn's disease	0.000178	0.0182	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Mesalazine—Crohn's disease	0.000171	0.0175	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Mercaptopurine—Crohn's disease	0.000162	0.0166	CcSEcCtD
Trisalicylate-choline—Weight increased—Mesalazine—Crohn's disease	0.000162	0.0166	CcSEcCtD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.00016	0.034	CbGpPWpGaD
Trisalicylate-choline—Sweating—Mesalazine—Crohn's disease	0.000152	0.0156	CcSEcCtD
Trisalicylate-choline—Epistaxis—Mesalazine—Crohn's disease	0.00015	0.0153	CcSEcCtD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000149	0.0317	CbGpPWpGaD
Trisalicylate-choline—Erythema multiforme—Azathioprine—Crohn's disease	0.000148	0.0151	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Prednisone—Crohn's disease	0.000143	0.0147	CcSEcCtD
Trisalicylate-choline—Hepatitis—Mesalazine—Crohn's disease	0.000143	0.0146	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Prednisone—Crohn's disease	0.000137	0.014	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Prednisone—Crohn's disease	0.000136	0.0139	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Mesalazine—Crohn's disease	0.000135	0.0138	CcSEcCtD
Trisalicylate-choline—Tinnitus—Mesalazine—Crohn's disease	0.000133	0.0136	CcSEcCtD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—CRP—Crohn's disease	0.00013	0.0276	CbGpPWpGaD
Trisalicylate-choline—Diarrhoea—Mercaptopurine—Crohn's disease	0.000128	0.0131	CcSEcCtD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.000127	0.027	CbGpPWpGaD
Trisalicylate-choline—Erythema—Mesalazine—Crohn's disease	0.000124	0.0127	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Mesalazine—Crohn's disease	0.000122	0.0124	CcSEcCtD
Trisalicylate-choline—Vomiting—Mercaptopurine—Crohn's disease	0.000119	0.0121	CcSEcCtD
Trisalicylate-choline—PTGS2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000118	0.0252	CbGpPWpGaD
Trisalicylate-choline—Rash—Mercaptopurine—Crohn's disease	0.000118	0.012	CcSEcCtD
Trisalicylate-choline—Dermatitis—Mercaptopurine—Crohn's disease	0.000118	0.012	CcSEcCtD
Trisalicylate-choline—Lethargy—Prednisone—Crohn's disease	0.000111	0.0114	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—Crohn's disease	0.000111	0.0236	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Crohn's disease	0.000111	0.0236	CbGpPWpGaD
Trisalicylate-choline—Nausea—Mercaptopurine—Crohn's disease	0.000111	0.0113	CcSEcCtD
Trisalicylate-choline—Hypotension—Azathioprine—Crohn's disease	0.000104	0.0106	CcSEcCtD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—CRP—Crohn's disease	0.000103	0.0219	CbGpPWpGaD
Trisalicylate-choline—Confusional state—Mesalazine—Crohn's disease	0.000102	0.0105	CcSEcCtD
Trisalicylate-choline—Oedema—Mesalazine—Crohn's disease	0.000101	0.0104	CcSEcCtD
Trisalicylate-choline—Shock—Mesalazine—Crohn's disease	9.97e-05	0.0102	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Mesalazine—Crohn's disease	9.8e-05	0.01	CcSEcCtD
Trisalicylate-choline—Anorexia—Mesalazine—Crohn's disease	9.66e-05	0.00988	CcSEcCtD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—GPX4—Crohn's disease	9.49e-05	0.0202	CbGpPWpGaD
Trisalicylate-choline—Hypotension—Mesalazine—Crohn's disease	9.47e-05	0.00969	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Azathioprine—Crohn's disease	9.17e-05	0.00938	CcSEcCtD
Trisalicylate-choline—Somnolence—Mesalazine—Crohn's disease	9.01e-05	0.00922	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Mesalazine—Crohn's disease	8.92e-05	0.00913	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Mesalazine—Crohn's disease	8.81e-05	0.00901	CcSEcCtD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—PTGS2—Crohn's disease	8.7e-05	0.0185	CbGpPWpGaD
Trisalicylate-choline—Pain—Mesalazine—Crohn's disease	8.66e-05	0.00887	CcSEcCtD
Trisalicylate-choline—Constipation—Mesalazine—Crohn's disease	8.66e-05	0.00887	CcSEcCtD
Trisalicylate-choline—Weight increased—Prednisone—Crohn's disease	8.58e-05	0.00878	CcSEcCtD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—CXCL8—Crohn's disease	8.44e-05	0.0179	CbGpPWpGaD
Trisalicylate-choline—Feeling abnormal—Mesalazine—Crohn's disease	8.35e-05	0.00854	CcSEcCtD
Trisalicylate-choline—Urticaria—Mesalazine—Crohn's disease	8.05e-05	0.00824	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Crohn's disease	7.78e-05	0.0166	CbGpPWpGaD
Trisalicylate-choline—Diarrhoea—Azathioprine—Crohn's disease	7.61e-05	0.00779	CcSEcCtD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—GPX4—Crohn's disease	7.53e-05	0.016	CbGpPWpGaD
Trisalicylate-choline—Hallucination—Prednisone—Crohn's disease	7.51e-05	0.00768	CcSEcCtD
Trisalicylate-choline—Dizziness—Azathioprine—Crohn's disease	7.36e-05	0.00753	CcSEcCtD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—MPO—Crohn's disease	7.24e-05	0.0154	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Eicosanoid Synthesis—PTGS2—Crohn's disease	7.22e-05	0.0153	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—Crohn's disease	7.19e-05	0.0153	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Mesalazine—Crohn's disease	7.17e-05	0.00734	CcSEcCtD
Trisalicylate-choline—Vomiting—Azathioprine—Crohn's disease	7.07e-05	0.00724	CcSEcCtD
Trisalicylate-choline—Rash—Azathioprine—Crohn's disease	7.01e-05	0.00718	CcSEcCtD
Trisalicylate-choline—Dermatitis—Azathioprine—Crohn's disease	7.01e-05	0.00717	CcSEcCtD
Trisalicylate-choline—Flushing—Prednisone—Crohn's disease	7e-05	0.00717	CcSEcCtD
Trisalicylate-choline—Headache—Azathioprine—Crohn's disease	6.97e-05	0.00713	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Mesalazine—Crohn's disease	6.93e-05	0.00709	CcSEcCtD
Trisalicylate-choline—Dizziness—Mesalazine—Crohn's disease	6.7e-05	0.00686	CcSEcCtD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—CXCL8—Crohn's disease	6.7e-05	0.0142	CbGpPWpGaD
Trisalicylate-choline—Nausea—Azathioprine—Crohn's disease	6.61e-05	0.00676	CcSEcCtD
Trisalicylate-choline—Erythema—Prednisone—Crohn's disease	6.57e-05	0.00672	CcSEcCtD
Trisalicylate-choline—Vomiting—Mesalazine—Crohn's disease	6.44e-05	0.00659	CcSEcCtD
Trisalicylate-choline—Rash—Mesalazine—Crohn's disease	6.39e-05	0.00654	CcSEcCtD
Trisalicylate-choline—Dermatitis—Mesalazine—Crohn's disease	6.38e-05	0.00653	CcSEcCtD
Trisalicylate-choline—Headache—Mesalazine—Crohn's disease	6.35e-05	0.0065	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	6.07e-05	0.0129	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	6.04e-05	0.0128	CbGpPWpGaD
Trisalicylate-choline—Nausea—Mesalazine—Crohn's disease	6.02e-05	0.00616	CcSEcCtD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—MPO—Crohn's disease	5.96e-05	0.0127	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—TNF—Crohn's disease	5.87e-05	0.0125	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—MPO—Crohn's disease	5.74e-05	0.0122	CbGpPWpGaD
Trisalicylate-choline—Oedema—Prednisone—Crohn's disease	5.36e-05	0.00549	CcSEcCtD
Trisalicylate-choline—Shock—Prednisone—Crohn's disease	5.27e-05	0.0054	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Prednisone—Crohn's disease	5.18e-05	0.0053	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Crohn's disease	5.13e-05	0.0109	CbGpPWpGaD
Trisalicylate-choline—Anorexia—Prednisone—Crohn's disease	5.11e-05	0.00523	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	5.03e-05	0.0107	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	4.74e-05	0.0101	CbGpPWpGaD
Trisalicylate-choline—Dyspepsia—Prednisone—Crohn's disease	4.72e-05	0.00483	CcSEcCtD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—TNF—Crohn's disease	4.66e-05	0.00991	CbGpPWpGaD
Trisalicylate-choline—Decreased appetite—Prednisone—Crohn's disease	4.66e-05	0.00477	CcSEcCtD
Trisalicylate-choline—Constipation—Prednisone—Crohn's disease	4.58e-05	0.00469	CcSEcCtD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—TAB1—Crohn's disease	4.49e-05	0.00955	CbGpPWpGaD
Trisalicylate-choline—Feeling abnormal—Prednisone—Crohn's disease	4.42e-05	0.00452	CcSEcCtD
Trisalicylate-choline—Urticaria—Prednisone—Crohn's disease	4.26e-05	0.00436	CcSEcCtD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.01e-05	0.00853	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	3.81e-05	0.00809	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Prednisone—Crohn's disease	3.79e-05	0.00388	CcSEcCtD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	3.76e-05	0.008	CbGpPWpGaD
Trisalicylate-choline—Diarrhoea—Prednisone—Crohn's disease	3.67e-05	0.00375	CcSEcCtD
Trisalicylate-choline—Dizziness—Prednisone—Crohn's disease	3.55e-05	0.00363	CcSEcCtD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	3.5e-05	0.00744	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.44e-05	0.00731	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Prednisone—Crohn's disease	3.41e-05	0.00349	CcSEcCtD
Trisalicylate-choline—Rash—Prednisone—Crohn's disease	3.38e-05	0.00346	CcSEcCtD
Trisalicylate-choline—Dermatitis—Prednisone—Crohn's disease	3.38e-05	0.00346	CcSEcCtD
Trisalicylate-choline—Headache—Prednisone—Crohn's disease	3.36e-05	0.00344	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	3.32e-05	0.00706	CbGpPWpGaD
Trisalicylate-choline—Nausea—Prednisone—Crohn's disease	3.18e-05	0.00326	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	3.09e-05	0.00657	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	3.02e-05	0.00642	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.92e-05	0.00621	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	2.92e-05	0.0062	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	2.78e-05	0.00591	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.73e-05	0.0058	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	2.66e-05	0.00566	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	2.55e-05	0.00543	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	2.46e-05	0.00523	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	2.37e-05	0.00505	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.32e-05	0.00493	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	2.32e-05	0.00492	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	2.3e-05	0.00489	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	2.29e-05	0.00487	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.28e-05	0.00484	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	2.2e-05	0.00467	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	2.15e-05	0.00457	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.13e-05	0.00453	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	2.12e-05	0.0045	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	2.11e-05	0.00449	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	1.88e-05	0.00401	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.81e-05	0.00384	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	1.72e-05	0.00366	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.69e-05	0.0036	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	1.67e-05	0.00355	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	1.55e-05	0.0033	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PLA2G4F—Crohn's disease	1.53e-05	0.00325	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	1.49e-05	0.00317	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	1.39e-05	0.00296	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	1.37e-05	0.00291	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MTMR3—Crohn's disease	1.3e-05	0.00277	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RSPO3—Crohn's disease	1.27e-05	0.0027	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PLA2G4F—Crohn's disease	1.21e-05	0.00258	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SEL1L—Crohn's disease	1.2e-05	0.00256	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	1.1e-05	0.00235	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	1.08e-05	0.0023	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LTF—Crohn's disease	1.08e-05	0.00229	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTMR3—Crohn's disease	1.03e-05	0.0022	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—FADS1—Crohn's disease	1.01e-05	0.00216	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GPX4—Crohn's disease	9.49e-06	0.00202	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GCKR—Crohn's disease	9.17e-06	0.00195	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	8.73e-06	0.00186	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GCKR—Crohn's disease	8.69e-06	0.00185	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—FADS1—Crohn's disease	8.05e-06	0.00171	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SLC11A1—Crohn's disease	7.68e-06	0.00163	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GPX4—Crohn's disease	7.54e-06	0.0016	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	7.36e-06	0.00156	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GCKR—Crohn's disease	7.28e-06	0.00155	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RBX1—Crohn's disease	6.59e-06	0.0014	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HSPA1B—Crohn's disease	6.59e-06	0.0014	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.55e-06	0.00139	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—UBE2D1—Crohn's disease	5.78e-06	0.00123	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.73e-06	0.00122	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.2e-06	0.00111	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SMAD3—Crohn's disease	4.13e-06	0.000879	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALB—Crohn's disease	2.92e-06	0.000621	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TYK2—Crohn's disease	2.7e-06	0.000573	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—JAK2—Crohn's disease	2.57e-06	0.000547	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTGS2—Crohn's disease	2.55e-06	0.000543	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CD4—Crohn's disease	2.44e-06	0.000518	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALB—Crohn's disease	2.32e-06	0.000493	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—STAT3—Crohn's disease	1.89e-06	0.000401	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6—Crohn's disease	1.32e-06	0.00028	CbGpPWpGaD
